Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CONVIVO In Vivo Pathology Suite

K-Number: K211156 · 2021-12-29

Decision Date2021-12-29
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CONVIVO In Vivo Pathology Suite is a medical device manufactured by Carl Zeiss Meditec, AG. It received FDA 510(k) clearance on 2021-12-29 under approval number K211156. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CONVIVO In Vivo Pathology Suite?

CONVIVO In Vivo Pathology Suite is a medical device that received FDA 510(k) clearance on 2021-12-29. It is manufactured by Carl Zeiss Meditec, AG. The 510(k) number is K211156.

When was CONVIVO In Vivo Pathology Suite approved by the FDA?

CONVIVO In Vivo Pathology Suite received FDA 510(k) clearance on 2021-12-29, under approval number K211156.

What company makes CONVIVO In Vivo Pathology Suite?

CONVIVO In Vivo Pathology Suite is manufactured by Carl Zeiss Meditec, AG.

What is the FDA product code for CONVIVO In Vivo Pathology Suite?

The FDA product code for CONVIVO In Vivo Pathology Suite is LLZ.

Other Devices by Carl Zeiss Meditec, AG

View all 26 devices →

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.